Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features.

Rosty C, Young JP, Walsh MD, Clendenning M, Walters RJ, Pearson S, Pavluk E, Nagler B, Pakenas D, Jass JR, Jenkins MA, Win AK, Southey MC, Parry S, Hopper JL, Giles GG, Williamson E, English DR, Buchanan DD.

Mod Pathol. 2013 Jun;26(6):825-34. doi: 10.1038/modpathol.2012.240. Epub 2013 Jan 25.

2.

Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.

Rosty C, Buchanan DD, Walsh MD, Pearson SA, Pavluk E, Walters RJ, Clendenning M, Spring KJ, Jenkins MA, Win AK, Hopper JL, Sweet K, Frankel WL, Aronson M, Gallinger S, Goldblatt J, Woodall S, Arnold J, Walker NI, Jass JR, Parry S, Young JP.

Am J Surg Pathol. 2012 Jun;36(6):876-82. doi: 10.1097/PAS.0b013e31824e133f.

3.

Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry.

Walsh MD, Buchanan DD, Pearson SA, Clendenning M, Jenkins MA, Win AK, Walters RJ, Spring KJ, Nagler B, Pavluk E, Arnold ST, Goldblatt J, George J, Suthers GK, Phillips K, Hopper JL, Jass JR, Baron JA, Ahnen DJ, Thibodeau SN, Lindor N, Parry S, Walker NI, Rosty C, Young JP.

Mod Pathol. 2012 May;25(5):722-30. doi: 10.1038/modpathol.2011.209. Epub 2012 Feb 10.

4.

Oncogenic PIK3CA mutations in colorectal cancers and polyps.

Whitehall VL, Rickman C, Bond CE, Ramsnes I, Greco SA, Umapathy A, McKeone D, Faleiro RJ, Buttenshaw RL, Worthley DL, Nayler S, Zhao ZZ, Montgomery GW, Mallitt KA, Jass JR, Matsubara N, Notohara K, Ishii T, Leggett BA.

Int J Cancer. 2012 Aug 15;131(4):813-20. doi: 10.1002/ijc.26440. Epub 2011 Nov 19.

5.

Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).

Roberts A, Nancarrow D, Clendenning M, Buchanan DD, Jenkins MA, Duggan D, Taverna D, McKeone D, Walters R, Walsh MD, Young BW, Jass JR, Rosty C, Gattas M, Pelzer E, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Parry S, Woodall S, Arnold J, Tucker K, Muir A, Drini M, Macrae F, Newcomb P, Potter JD, Pavluk E, Lindblom A, Young JP.

Fam Cancer. 2011 Jun;10(2):245-54. doi: 10.1007/s10689-010-9408-8.

6.

Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study.

Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, Gattas M, Walsh MD, Clendenning M, McKeone D, Walters R, Roberts A, Young A, Hampel H, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Young GP, Chow E, Parry S, Woodall S, Tucker K, Muir A, Field M, Greening S, Gallinger S, Green J, Woods MO, Spaetgens R, de la Chapelle A, Macrae F, Walker NI, Jass JR, Young JP.

Int J Colorectal Dis. 2010 Jun;25(6):703-12. doi: 10.1007/s00384-010-0907-8. Epub 2010 Mar 6. Erratum in: Int J Colorectal Dis. 2010 Dec;25(12):1513-5.

7.

Pragmatic classification of superficial neoplastic colorectal lesions.

Lambert R, Kudo SE, Vieth M, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Jass JR, Triadafilopoulos G.

Gastrointest Endosc. 2009 Dec;70(6):1182-99. doi: 10.1016/j.gie.2009.09.015. Epub 2009 Oct 31. No abstract available.

PMID:
19879563
8.

HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers.

Walsh MD, Dent OF, Young JP, Wright CM, Barker MA, Leggett BA, Bokey L, Chapuis PH, Jass JR, Macdonald GA.

Int J Cancer. 2009 Sep 1;125(5):1231-7. doi: 10.1002/ijc.24484.

9.

High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families.

Chong G, Jarry J, Marcus V, Thiffault I, Winocour S, Monczak Y, Drouin R, Latreille J, Australie K, Bapat B, Gordon PH, Giguère Y, Gologan A, Galiatsatos P, Jass JR, Wong N, Zaor S, Palma L, Kasprzak L, Tischkowitz M, Foulkes WD.

Hum Mutat. 2009 Aug;30(8):E797-812. doi: 10.1002/humu.21056.

PMID:
19459153
10.

The association of tumor microsatellite instability phenotype with family history of colorectal cancer.

Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP, Cotterchio M, Jenkins M, Grove J, Casey G, Thibodeau SN, Bishop DT, Hopper JL, Ahnen D, Newcomb PA, Le Marchand L, Potter JD, Seminara D; Colon Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):967-75. doi: 10.1158/1055-9965.EPI-08-0878. Epub 2009 Mar 3.

11.

Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis.

Walsh MD, Buchanan DD, Walters R, Roberts A, Arnold S, McKeone D, Clendenning M, Ruszkiewicz AR, Jenkins MA, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Young GP, Macrae F, Drini M, Woods MO, Parry S, Jass JR, Young JP.

Fam Cancer. 2009;8(4):313-23. doi: 10.1007/s10689-009-9238-8. Epub 2009 Feb 25.

12.

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

Burn J, Bishop DT, Mecklin JP, Macrae F, Möslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans DG, Lubinski J, Morrison PJ, Ho JW, Vasen HF, Side L, Thomas HJ, Scott RJ, Dunlop M, Barker G, Elliott F, Jass JR, Fodde R, Lynch HT, Mathers JC; CAPP2 Investigators.

N Engl J Med. 2008 Dec 11;359(24):2567-78. doi: 10.1056/NEJMoa0801297. Erratum in: N Engl J Med. 2009 Apr 2;360(14):1470.

13.

Nonpolypoid neoplastic lesions of the colorectal mucosa.

Kudo Se, Lambert R, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Triadafilopoulos G, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Vieth M, Jass JR, Hurlstone PD.

Gastrointest Endosc. 2008 Oct;68(4 Suppl):S3-47. doi: 10.1016/j.gie.2008.07.052. Review. No abstract available.

PMID:
18805238
14.

Colorectal polyposes: from phenotype to diagnosis.

Jass JR.

Pathol Res Pract. 2008;204(7):431-47. doi: 10.1016/j.prp.2008.03.008. Epub 2008 Jun 9. Review.

PMID:
18541388
15.

MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells.

Baker K, Foulkes WD, Jass JR.

Cancer Immunol Immunother. 2009 Jan;58(1):135-44. doi: 10.1007/s00262-008-0534-1. Epub 2008 May 17.

PMID:
18488217
16.

Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.

Zlobec I, Terracciano L, Tornillo L, Günthert U, Vuong T, Jass JR, Lugli A.

Gut. 2008 Oct;57(10):1413-9. doi: 10.1136/gut.2007.141192. Epub 2008 Apr 24.

PMID:
18436576
17.

Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management.

East JE, Saunders BP, Jass JR.

Gastroenterol Clin North Am. 2008 Mar;37(1):25-46, v. doi: 10.1016/j.gtc.2007.12.014. Review.

PMID:
18313538
18.

Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development.

Loh K, Chia JA, Greco S, Cozzi SJ, Buttenshaw RL, Bond CE, Simms LA, Pike T, Young JP, Jass JR, Spring KJ, Leggett BA, Whitehall VL.

Genes Chromosomes Cancer. 2008 Jun;47(6):449-60. doi: 10.1002/gcc.20552.

PMID:
18311777
19.

Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.

Walsh MD, Cummings MC, Buchanan DD, Dambacher WM, Arnold S, McKeone D, Byrnes R, Barker MA, Leggett BA, Gattas M, Jass JR, Spurdle AB, Young J, Obermair A.

Clin Cancer Res. 2008 Mar 15;14(6):1692-700. doi: 10.1158/1078-0432.CCR-07-1849. Epub 2008 Feb 29.

20.

Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.

Zlobec I, Vuong T, Compton CC, Lugli A, Michel RP, Hayashi S, Jass JR.

Br J Cancer. 2008 Jan 29;98(2):450-6. doi: 10.1038/sj.bjc.6604172. Epub 2008 Jan 8.

21.

Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.

Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A.

Clin Cancer Res. 2008 Jan 1;14(1):143-8. doi: 10.1158/1078-0432.CCR-07-1380.

22.

Recommendations for the reporting of surgically resected specimens of colorectal carcinoma: Association of Directors of Anatomic and Surgical Pathology.

Jass JR, O'Brien J, Riddell RH, Snover DC; Association of Directors of Anatomic and Surgical Pathology.

Am J Clin Pathol. 2008 Jan;129(1):13-23. No abstract available.

PMID:
18089485
23.

Colorectal cancer cells express functional cell surface-bound TGFbeta.

Baker K, Raut P, Jass JR.

Int J Cancer. 2008 Apr 15;122(8):1695-700.

24.

Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.

Zlobec I, Minoo P, Baumhoer D, Baker K, Terracciano L, Jass JR, Lugli A.

Cancer. 2008 Feb 1;112(3):495-502.

25.

Molecular heterogeneity of colorectal cancer: Implications for cancer control.

Jass JR.

Surg Oncol. 2007 Dec;16 Suppl 1:S7-9. Epub 2007 Nov 26. Review.

PMID:
18023574
26.

Gastrointestinal polyposes: clinical, pathological and molecular features.

Jass JR.

Gastroenterol Clin North Am. 2007 Dec;36(4):927-46, viii. Review.

PMID:
17996798
27.

The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability.

Houston AM, Michael-Robinson JM, Walsh MD, Cummings MC, Ryan AE, Lincoln D, Pandeya N, Jass JR, Radford-Smith GL, O'Connell J.

Hum Pathol. 2008 Feb;39(2):243-50. Epub 2007 Oct 24.

PMID:
17961631
28.

Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.

Rubin DT, Cruz-Correa MR, Gasche C, Jass JR, Lichtenstein GR, Montgomery EA, Riddell RH, Rutter MD, Ullman TA, Velayos FS, Itzkowitz S; 5-ASA in Colorectal Cancer Prevention Meeting Group.

Inflamm Bowel Dis. 2008 Feb;14(2):265-74. Review.

PMID:
17932965
29.
30.

Types of colorectal adenoma.

Lugli A, Jass JR.

Verh Dtsch Ges Pathol. 2006;90:18-24.

PMID:
17867575
31.

Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.

Murphy J, Pocard M, Jass JR, O'Sullivan GC, Lee G, Talbot IC.

Dis Colon Rectum. 2007 Oct;50(10):1526-34.

PMID:
17828403
32.

Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer.

Zlobec I, Terracciano L, Jass JR, Lugli A.

Virchows Arch. 2007 Oct;451(4):763-9. Epub 2007 Aug 3.

PMID:
17674041
33.

Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.

Jenkins MA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, Waring PM, Ruszkiewicz AR, Pollett AF, Redston M, Barker MA, Baron JA, Casey GR, Dowty JG, Giles GG, Limburg P, Newcomb P, Young JP, Walsh MD, Thibodeau SN, Lindor NM, Lemarchand L, Gallinger S, Haile RW, Potter JD, Hopper JL, Jass JR; Colon Cancer Family Registry.

Gastroenterology. 2007 Jul;133(1):48-56. Epub 2007 Apr 25.

34.

Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.

Zlobec I, Lugli A, Baker K, Roth S, Minoo P, Hayashi S, Terracciano L, Jass JR.

J Pathol. 2007 Jul;212(3):260-8.

PMID:
17516584
35.

Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.

Lugli A, Zlobec I, Minoo P, Baker K, Tornillo L, Terracciano L, Jass JR.

Histopathology. 2007 Mar;50(4):453-64.

PMID:
17448021
36.

Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.

Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A.

Am J Clin Pathol. 2007 May;127(5):820-7.

PMID:
17439843
37.

Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.

Minoo P, Moyer MP, Jass JR.

J Pathol. 2007 Jun;212(2):124-33.

PMID:
17427169
38.

Colorectal cancer: a multipathway disease.

Jass JR.

Crit Rev Oncog. 2006 Dec;12(3-4):273-87. Review.

PMID:
17425506
39.

The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas.

Walsh MD, Young JP, Leggett BA, Williams SH, Jass JR, McGuckin MA.

Hum Pathol. 2007 Jun;38(6):883-92. Epub 2007 Mar 13.

PMID:
17360025
40.

Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.

Zlobec I, Minoo P, Baker K, Haegert D, Khetani K, Tornillo L, Terracciano L, Jass JR, Lugli A.

Eur J Cancer. 2007 Apr;43(6):1101-7. Epub 2007 Mar 12.

PMID:
17350821
41.

Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.

Herath NI, Walsh MD, Kew M, Smith JL, Jass JR, Young J, Leggett BA, Macdonald GA.

Oncol Rep. 2007 Apr;17(4):817-22.

PMID:
17342321
42.

Recommendations for the reporting of surgically resected specimens of colorectal carcinoma.

Jass JR, O'Brien MJ, Riddell RH, Snover DC; Association of Directors of Anatomic and Surgical Pathology (ADASP).

Virchows Arch. 2007 Jan;450(1):1-13. Epub 2006 Nov 25. No abstract available.

PMID:
17334800
43.

Wnt pathway may not be implicated in all routes to colorectal cancer.

Jass JR.

Gut. 2007 Feb;56(2):309; author reply 309-10. No abstract available.

44.

Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer.

Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A.

Mod Pathol. 2007 Mar;20(3):331-8. Epub 2007 Feb 2.

45.

Low frequency of promoter methylation of O6-methylguanine DNA methyltransferase and hMLH1 in ulcerative colitis-associated tumors: comparison with sporadic colonic tumors.

Mikami T, Yoshida T, Numata Y, Shiraishi H, Araki K, Guiot MC, Jass JR, Okayasu I.

Am J Clin Pathol. 2007 Mar;127(3):366-73.

PMID:
17276933
46.

Recommendations for the reporting of surgically resected specimens of colorectal carcinoma.

Jass JR, O'Brien MJ, Riddell RH, Snover DC; Association of Directors of Anatomic and Surgical Pathology.

Hum Pathol. 2007 Apr;38(4):537-545. Epub 2007 Feb 1.

PMID:
17270246
47.

Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer.

Kohonen-Corish MR, Sigglekow ND, Susanto J, Chapuis PH, Bokey EL, Dent OF, Chan C, Lin BP, Seng TJ, Laird PW, Young J, Leggett BA, Jass JR, Sutherland RL.

Oncogene. 2007 Jun 28;26(30):4435-41. Epub 2007 Jan 29.

PMID:
17260021
49.

Poorly differentiated tumours of the anal canal: a diagnostic strategy for the surgical pathologist.

Balachandra B, Marcus V, Jass JR.

Histopathology. 2007 Jan;50(1):163-74. Review.

PMID:
17204029
50.

Supplemental Content

Support Center